|
Analogs
-
4212843
-
-
607790
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 53 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Q862F3-2-E |
Tubulin Alpha Chain (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2500 |
0.27 |
Binding ≤ 10μM |
Q862L2-2-E |
Tubulin Alpha-1 Chain (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2500 |
0.27 |
Binding ≤ 10μM |
TBA1A-1-E |
Tubulin Alpha-3 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
5750 |
0.25 |
Binding ≤ 10μM
|
TBA4A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2700 |
0.27 |
Binding ≤ 10μM
|
TBB-1-E |
Tubulin Beta Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1260 |
0.28 |
Binding ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
800 |
0.29 |
Binding ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
780 |
0.29 |
Binding ≤ 10μM
|
TBB3-1-E |
Tubulin Beta-3 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5750 |
0.25 |
Binding ≤ 10μM
|
TBB4A-1-E |
Tubulin Beta-4 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.30 |
Binding ≤ 10μM
|
TBB4B-1-E |
Tubulin Beta-2 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.30 |
Binding ≤ 10μM
|
TBB5-1-E |
Tubulin Beta-5 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5750 |
0.25 |
Binding ≤ 10μM
|
TBB8-1-E |
Tubulin Beta-8 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.30 |
Binding ≤ 10μM
|
TBG1-1-E |
Tubulin Gamma-1 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5750 |
0.25 |
Binding ≤ 10μM
|
Q862F3-1-E |
Tubulin Alpha Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8700 |
0.24 |
Functional ≤ 10μM
|
Q862L2-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8700 |
0.24 |
Functional ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
800 |
0.29 |
Functional ≤ 10μM
|
TBA4A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1700 |
0.28 |
Functional ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
800 |
0.29 |
Functional ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8700 |
0.24 |
Functional ≤ 10μM
|
TBB3-1-E |
Tubulin Beta-3 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4200 |
0.26 |
Functional ≤ 10μM
|
TBB4A-1-E |
Tubulin Beta-4 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4200 |
0.26 |
Functional ≤ 10μM
|
TBB4B-1-E |
Tubulin Beta-2 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4200 |
0.26 |
Functional ≤ 10μM
|
TBB5-1-E |
Tubulin Beta-5 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3300 |
0.26 |
Functional ≤ 10μM
|
TBB8-1-E |
Tubulin Beta-8 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4200 |
0.26 |
Functional ≤ 10μM
|
Z101682-1-O |
BK Polyomavirus (cluster #1 Of 2), Other |
Other |
22 |
0.37 |
Functional ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
20 |
0.37 |
Functional ≤ 10μM |
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
53 |
0.35 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
10000 |
0.24 |
Functional ≤ 10μM
|
Z50590-1-O |
Sus Scrofa (cluster #1 Of 1), Other |
Other |
1400 |
0.28 |
Functional ≤ 10μM
|
Z50607-1-O |
Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other |
Other |
18 |
0.37 |
Functional ≤ 10μM |
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
12 |
0.38 |
Functional ≤ 10μM
|
Z80024-1-O |
A9 (Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
14 |
0.38 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.36 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
31 |
0.36 |
Functional ≤ 10μM
|
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
220 |
0.32 |
Functional ≤ 10μM |
Z80096-1-O |
CHO-TAX 5-6 (cluster #1 Of 2), Other |
Other |
140 |
0.33 |
Functional ≤ 10μM |
Z80097-1-O |
CHO-VV 3-2 (cluster #1 Of 2), Other |
Other |
620 |
0.30 |
Functional ≤ 10μM |
Z80120-1-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
190 |
0.32 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
10 |
0.39 |
Functional ≤ 10μM |
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
53 |
0.35 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
1 |
0.43 |
Functional ≤ 10μM |
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
22 |
0.37 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
7 |
0.39 |
Functional ≤ 10μM |
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
7 |
0.39 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
6 |
0.40 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
1900 |
0.28 |
Functional ≤ 10μM |
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
7 |
0.39 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
15 |
0.38 |
Functional ≤ 10μM
|
Z80354-1-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
800 |
0.29 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
10 |
0.39 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
33 |
0.36 |
Functional ≤ 10μM |
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
14 |
0.38 |
Functional ≤ 10μM
|
Z80427-1-O |
RKO (Colon Carcinoma) (cluster #1 Of 1), Other |
Other |
20 |
0.37 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
50 |
0.35 |
Functional ≤ 10μM |
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
5 |
0.40 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
71 |
0.35 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
30 |
0.36 |
Functional ≤ 10μM |
Z80566-1-O |
U-937 (Histiocytic Lymphoma Cells) (cluster #1 Of 2), Other |
Other |
5 |
0.40 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
390 |
0.31 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
6 |
0.40 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
45 |
0.35 |
Functional ≤ 10μM
|
Z80711-1-O |
NCI/ADR-RES (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
1113 |
0.29 |
Functional ≤ 10μM |
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
9 |
0.39 |
Functional ≤ 10μM
|
Z80720-1-O |
Burkitts Lymphoma Cells (cluster #1 Of 1), Other |
Other |
50 |
0.35 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
52 |
0.35 |
Functional ≤ 10μM |
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
3 |
0.41 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
8 |
0.39 |
Functional ≤ 10μM |
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
40 |
0.36 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
50 |
0.35 |
Functional ≤ 10μM |
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
70 |
0.35 |
Functional ≤ 10μM |
Z81054-2-O |
SF-268 (Glioblastoma Cells) (cluster #2 Of 3), Other |
Other |
50 |
0.35 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
17 |
0.38 |
Functional ≤ 10μM |
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
6 |
0.40 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
20 |
0.37 |
Functional ≤ 10μM |
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
93 |
0.34 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
7 |
0.39 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
39 |
0.36 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
70 |
0.35 |
Functional ≤ 10μM
|
Z81281-1-O |
NCI-H23 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 5), Other |
Other |
13 |
0.38 |
Functional ≤ 10μM |
Z81283-1-O |
NCI-H522 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
14 |
0.38 |
Functional ≤ 10μM |
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
14 |
0.38 |
Functional ≤ 10μM |
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
140 |
0.33 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
530 |
0.30 |
ADME/T ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
522 |
0.30 |
ADME/T ≤ 10μM
|
Z80897-1-O |
H9 (T-lymphoid Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.39 |
ADME/T ≤ 10μM |
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
3 |
0.41 |
ADME/T ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 3), Other |
Other |
210 |
0.32 |
ADME/T ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
2 |
0.42 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.10 |
7.99 |
-20.74 |
1 |
7 |
0 |
83 |
399.443 |
5 |
↓
|
|
|
Analogs
-
9805467
-
-
9805468
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80354-1-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
3350 |
0.21 |
Functional ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
7940 |
0.20 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.67 |
1.02 |
-56.92 |
0 |
6 |
-1 |
83 |
493.564 |
4 |
↓
|
|
|
Analogs
-
9805467
-
-
9805468
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80354-1-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
3350 |
0.21 |
Functional ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
7940 |
0.20 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.67 |
0.92 |
-57.17 |
0 |
6 |
-1 |
83 |
493.564 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
RARA-1-E |
Retinoic Acid Receptor Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6500 |
0.24 |
Binding ≤ 10μM
|
RARB-1-E |
Retinoic Acid Receptor Beta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2480 |
0.26 |
Binding ≤ 10μM
|
RARG-1-E |
Retinoic Acid Receptor Gamma (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
77 |
0.33 |
Binding ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
280 |
0.31 |
Functional ≤ 10μM
|
Z80135-1-O |
F9 (cluster #1 Of 1), Other |
Other |
33 |
0.35 |
Functional ≤ 10μM
|
Z80140-1-O |
GBM (cluster #1 Of 1), Other |
Other |
550 |
0.29 |
Functional ≤ 10μM
|
Z80211-2-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
490 |
0.29 |
Functional ≤ 10μM
|
Z80250-1-O |
Me665/2/21 (cluster #1 Of 1), Other |
Other |
420 |
0.30 |
Functional ≤ 10μM
|
Z80306-1-O |
NB-4 (Promyelocytic Leukemia Cells) (cluster #1 Of 1), Other |
Other |
400 |
0.30 |
Functional ≤ 10μM
|
Z80354-1-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
130 |
0.32 |
Functional ≤ 10μM |
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
430 |
0.30 |
Functional ≤ 10μM
|
Z80449-1-O |
SAOS-2 (Osteosarcoma Cells) (cluster #1 Of 1), Other |
Other |
670 |
0.29 |
Functional ≤ 10μM
|
Z80561-1-O |
U2OS (Osteosarcoma Cells) (cluster #1 Of 1), Other |
Other |
440 |
0.30 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
510 |
0.29 |
Functional ≤ 10μM
|
Z80928-6-O |
HCT-116 (Colon Carcinoma Cells) (cluster #6 Of 9), Other |
Other |
680 |
0.29 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
430 |
0.30 |
Functional ≤ 10μM
|
Z81065-1-O |
IGROV-1 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
350 |
0.30 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
320 |
0.30 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
7.63 |
13.65 |
-51.5 |
1 |
3 |
-1 |
60 |
397.494 |
3 |
↓
|
|
|
Analogs
-
5947366
-
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.32 |
3.38 |
-17.44 |
1 |
4 |
0 |
56 |
187.202 |
1 |
↓
|
|
|
Analogs
-
3916314
-
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.32 |
3.38 |
-17.47 |
1 |
4 |
0 |
56 |
187.202 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
DYR-1-E |
Dihydrofolate Reductase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
52 |
0.24 |
Binding ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
2 |
0.29 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
650 |
0.21 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
10 |
0.27 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
1 |
0.30 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM
|
Z80192-1-O |
KM12 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
3 |
0.28 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
1 |
0.30 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
4 |
0.28 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
3 |
0.28 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
5 |
0.28 |
Functional ≤ 10μM
|
Z80354-1-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
46 |
0.24 |
Functional ≤ 10μM
|
Z80356-1-O |
OVCAR-5 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
3 |
0.28 |
Functional ≤ 10μM
|
Z80357-1-O |
OVCAR-8 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
2 |
0.29 |
Functional ≤ 10μM
|
Z80438-1-O |
RXF 393 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
9 |
0.27 |
Functional ≤ 10μM
|
Z80457-1-O |
SCC-25 (cluster #1 Of 1), Other |
Other |
1 |
0.30 |
Functional ≤ 10μM
|
Z80459-1-O |
SCC-7 (cluster #1 Of 1), Other |
Other |
1 |
0.30 |
Functional ≤ 10μM
|
Z80468-1-O |
SF-295 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
1 |
0.30 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
5 |
0.28 |
Functional ≤ 10μM
|
Z80488-2-O |
SK-MEL-5 (Melanoma Cells) (cluster #2 Of 3), Other |
Other |
6 |
0.27 |
Functional ≤ 10μM
|
Z80551-1-O |
TK-10 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
10 |
0.27 |
Functional ≤ 10μM
|
Z80560-1-O |
U-251 (Glioma Cells) (cluster #1 Of 3), Other |
Other |
5 |
0.28 |
Functional ≤ 10μM
|
Z80568-1-O |
UACC-257 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
25 |
0.25 |
Functional ≤ 10μM
|
Z80570-3-O |
UACC-62 (Melanoma Cells) (cluster #3 Of 3), Other |
Other |
2 |
0.29 |
Functional ≤ 10μM
|
Z80575-1-O |
UO-31 (Renal Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
6 |
0.27 |
Functional ≤ 10μM
|
Z80640-1-O |
786-0 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
1 |
0.30 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
1 |
0.30 |
Functional ≤ 10μM
|
Z80711-1-O |
NCI/ADR-RES (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
3 |
0.28 |
Functional ≤ 10μM
|
Z80834-1-O |
EKVX (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
23 |
0.25 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
440 |
0.21 |
Functional ≤ 10μM
|
Z80920-1-O |
HCC 2998 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
1 |
0.30 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM
|
Z80972-1-O |
HOP-92 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
8 |
0.27 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
1 |
0.30 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
3 |
0.28 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
5 |
0.28 |
Functional ≤ 10μM |
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM
|
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
3 |
0.28 |
Functional ≤ 10μM
|
Z81248-1-O |
Malme-3M (Melanoma Cells) (cluster #1 Of 3), Other |
Other |
2 |
0.29 |
Functional ≤ 10μM
|
Z81281-1-O |
NCI-H23 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 5), Other |
Other |
4 |
0.28 |
Functional ≤ 10μM
|
Z81283-1-O |
NCI-H522 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
7 |
0.27 |
Functional ≤ 10μM
|
Z81322-1-O |
SF-539 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
4 |
0.28 |
Functional ≤ 10μM
|
Z81325-1-O |
SR (Leukemia Cells) (cluster #1 Of 2), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
2 |
0.29 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
1 |
0.30 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.11 |
-10.62 |
-142.86 |
7 |
15 |
-2 |
254 |
571.554 |
12 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CDK4-2-E |
Cyclin-dependent Kinase 4 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
550 |
0.42 |
Binding ≤ 10μM
|
CDK6-1-E |
Cyclin-dependent Kinase 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3400 |
0.36 |
Binding ≤ 10μM
|
Z50426-1-O |
Plasmodium Falciparum (isolate K1 / Thailand) (cluster #1 Of 9), Other |
Other |
184 |
0.45 |
Functional ≤ 10μM
|
Z50725-7-O |
Trypanosoma Brucei Rhodesiense (cluster #7 Of 7), Other |
Other |
630 |
0.41 |
Functional ≤ 10μM
|
Z80021-2-O |
A498 (Renal Carcinoma Cells) (cluster #2 Of 5), Other |
Other |
5200 |
0.35 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
4900 |
0.35 |
Functional ≤ 10μM
|
Z80192-1-O |
KM12 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
4600 |
0.36 |
Functional ≤ 10μM
|
Z80214-1-O |
M14 (Melanoma Cells) (cluster #1 Of 3), Other |
Other |
920 |
0.40 |
Functional ≤ 10μM
|
Z80354-1-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
1500 |
0.39 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
9300 |
0.34 |
Functional ≤ 10μM
|
Z80488-1-O |
SK-MEL-5 (Melanoma Cells) (cluster #1 Of 3), Other |
Other |
2000 |
0.38 |
Functional ≤ 10μM
|
Z80498-1-O |
SN12C (Renal Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
4200 |
0.36 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
3600 |
0.36 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
4200 |
0.36 |
Functional ≤ 10μM
|
Z80889-1-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
5000 |
0.35 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
600 |
0.41 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
4200 |
0.36 |
Functional ≤ 10μM
|
Z81245-3-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #3 Of 6), Other |
Other |
560 |
0.42 |
Functional ≤ 10μM
|
Z81246-2-O |
MDA-N (Breast Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
560 |
0.42 |
Functional ≤ 10μM
|
Z81248-1-O |
Malme-3M (Melanoma Cells) (cluster #1 Of 3), Other |
Other |
360 |
0.43 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
9600 |
0.33 |
Functional ≤ 10μM
|
Z81281-2-O |
NCI-H23 (Non-small Cell Lung Carcinoma Cells) (cluster #2 Of 5), Other |
Other |
4500 |
0.36 |
Functional ≤ 10μM
|
Z81283-1-O |
NCI-H522 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
4500 |
0.36 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
3700 |
0.36 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.28 |
0.73 |
-32.06 |
1 |
3 |
1 |
36 |
271.299 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.25 |
1.64 |
-19.63 |
1 |
5 |
0 |
69 |
188.19 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.25 |
1.65 |
-19.63 |
1 |
5 |
0 |
69 |
188.19 |
1 |
↓
|
|
|
Analogs
-
6920406
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 72 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
B0BL08-1-B |
Dihydrofolate Reductase (cluster #1 Of 1), Bacterial |
Bacteria |
9 |
0.34 |
Binding ≤ 10μM
|
DYR-1-B |
Dihydrofolate Reductase (cluster #1 Of 4), Bacterial |
Bacteria |
7 |
0.35 |
Binding ≤ 10μM
|
DYR-1-B |
Dihydrofolate Reductase (cluster #1 Of 4), Bacterial |
Bacteria |
9 |
0.34 |
Binding ≤ 10μM
|
DYR1-1-B |
Dihydrofolate Reductase Type 1 (cluster #1 Of 1), Bacterial |
Bacteria |
7 |
0.35 |
Binding ≤ 10μM
|
DYR1-1-B |
Dihydrofolate Reductase Type 1 (cluster #1 Of 1), Bacterial |
Bacteria |
9 |
0.34 |
Binding ≤ 10μM
|
Q81R22-1-B |
Dihydrofolate Reductase (cluster #1 Of 1), Bacterial |
Bacteria |
15 |
0.33 |
Binding ≤ 10μM
|
TYSY-1-B |
Thymidylate Synthase (cluster #1 Of 1), Bacterial |
Bacteria |
1800 |
0.24 |
Binding ≤ 10μM
|
DYR-1-B |
Dihydrofolate Reductase (cluster #1 Of 1), Bacterial |
Bacteria |
26 |
0.32 |
Functional ≤ 10μM
|
DRTS-1-E |
Bifunctional Dihydrofolate Reductase-thymidylate Synthase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
11 |
0.34 |
Binding ≤ 10μM
|
DRTS-1-E |
Bifunctional Dihydrofolate Reductase-thymidylate Synthase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
33 |
0.32 |
Binding ≤ 10μM
|
DYR-1-E |
Dihydrofolate Reductase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
3 |
0.36 |
Binding ≤ 10μM |
DYR-1-E |
Dihydrofolate Reductase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
5 |
0.35 |
Binding ≤ 10μM
|
FOLC-1-E |
Folylpoly-gamma-glutamate Synthetase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3200 |
0.23 |
Binding ≤ 10μM
|
PTR1-1-E |
Pteridine Reductase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
39 |
0.31 |
Binding ≤ 10μM
|
S19A1-1-E |
Folate Transporter 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3500 |
0.23 |
Binding ≤ 10μM
|
TYSY-1-E |
Thymidylate Synthase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
3600 |
0.23 |
Binding ≤ 10μM
|
DYR-1-F |
Dihydrofolate Reductase (cluster #1 Of 1), Fungal |
Fungi |
880 |
0.26 |
Binding ≤ 10μM
|
Z103204-2-O |
A427 (cluster #2 Of 4), Other |
Other |
5520 |
0.22 |
Functional ≤ 10μM
|
Z50266-1-O |
Enterococcus Faecium (cluster #1 Of 1), Other |
Other |
90 |
0.30 |
Functional ≤ 10μM
|
Z50362-1-O |
Lactobacillus Casei (cluster #1 Of 1), Other |
Other |
6 |
0.35 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
85 |
0.30 |
Functional ≤ 10μM
|
Z50587-1-O |
Homo Sapiens (cluster #1 Of 9), Other |
Other |
6600 |
0.22 |
Functional ≤ 10μM
|
Z50594-1-O |
Mus Musculus (cluster #1 Of 9), Other |
Other |
4200 |
0.23 |
Functional ≤ 10μM
|
Z80001-1-O |
143B (cluster #1 Of 2), Other |
Other |
9 |
0.34 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
16 |
0.33 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.31 |
Functional ≤ 10μM
|
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
1100 |
0.25 |
Functional ≤ 10μM
|
Z80063-1-O |
CCRF S-180 (cluster #1 Of 1), Other |
Other |
10 |
0.34 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
8 |
0.34 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
620 |
0.26 |
Functional ≤ 10μM
|
Z80099-1-O |
COLO 205 (Colon Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
870 |
0.26 |
Functional ≤ 10μM
|
Z80112-1-O |
DAN-G (cluster #1 Of 2), Other |
Other |
77 |
0.30 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
45 |
0.31 |
Functional ≤ 10μM
|
Z80132-1-O |
EL4 (Thymoma Cells) (cluster #1 Of 2), Other |
Other |
1570 |
0.25 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
7 |
0.35 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
8 |
0.34 |
Functional ≤ 10μM
|
Z80166-12-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #12 Of 12), Other |
Other |
4400 |
0.23 |
Functional ≤ 10μM |
Z80171-1-O |
HuTu80 (cluster #1 Of 1), Other |
Other |
9 |
0.34 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
26 |
0.32 |
Functional ≤ 10μM
|
Z80192-1-O |
KM12 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
42 |
0.31 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
10 |
0.34 |
Functional ≤ 10μM
|
Z80214-1-O |
M14 (Melanoma Cells) (cluster #1 Of 3), Other |
Other |
32 |
0.32 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
900 |
0.26 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
78 |
0.30 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
28 |
0.32 |
Functional ≤ 10μM
|
Z80354-1-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
400 |
0.27 |
Functional ≤ 10μM
|
Z80356-1-O |
OVCAR-5 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
980 |
0.25 |
Functional ≤ 10μM
|
Z80357-1-O |
OVCAR-8 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
31 |
0.32 |
Functional ≤ 10μM
|
Z80362-8-O |
P388 (Lymphoma Cells) (cluster #8 Of 8), Other |
Other |
66 |
0.30 |
Functional ≤ 10μM |
Z80390-3-O |
PC-3 (Prostate Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
27 |
0.32 |
Functional ≤ 10μM
|
Z80407-1-O |
R1 (cluster #1 Of 1), Other |
Other |
720 |
0.26 |
Functional ≤ 10μM
|
Z80408-1-O |
R1-CCRF-CEM (Lymphoblastic Leukemia) (cluster #1 Of 1), Other |
Other |
985 |
0.25 |
Functional ≤ 10μM
|
Z80409-1-O |
R2 (cluster #1 Of 1), Other |
Other |
216 |
0.28 |
Functional ≤ 10μM
|
Z80409-1-O |
R2 (cluster #1 Of 1), Other |
Other |
2600 |
0.24 |
Functional ≤ 10μM
|
Z80410-1-O |
R2-CCRF-CEM (Lymphoblastic Leukemia) (cluster #1 Of 1), Other |
Other |
2630 |
0.24 |
Functional ≤ 10μM
|
Z80411-1-O |
R30dm-CCRF-CEM (Lymphoblastic Leukemia) (cluster #1 Of 1), Other |
Other |
18 |
0.33 |
Functional ≤ 10μM
|
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.31 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
33 |
0.32 |
Functional ≤ 10μM
|
Z80443-1-O |
S180 (Sarcoma Cells) (cluster #1 Of 1), Other |
Other |
5 |
0.35 |
Functional ≤ 10μM
|
Z80455-1-O |
SCC-15 (cluster #1 Of 1), Other |
Other |
580 |
0.26 |
Functional ≤ 10μM
|
Z80457-1-O |
SCC-25 (cluster #1 Of 1), Other |
Other |
8 |
0.34 |
Functional ≤ 10μM
|
Z80459-1-O |
SCC-7 (cluster #1 Of 1), Other |
Other |
6 |
0.35 |
Functional ≤ 10μM
|
Z80468-1-O |
SF-295 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
36 |
0.32 |
Functional ≤ 10μM
|
Z80488-2-O |
SK-MEL-5 (Melanoma Cells) (cluster #2 Of 3), Other |
Other |
87 |
0.30 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
15 |
0.33 |
Functional ≤ 10μM
|
Z80560-1-O |
U-251 (Glioma Cells) (cluster #1 Of 3), Other |
Other |
63 |
0.31 |
Functional ≤ 10μM
|
Z80563-1-O |
U-373 MG ( Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
12 |
0.34 |
Functional ≤ 10μM
|
Z80565-1-O |
U-87 MG (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
22 |
0.32 |
Functional ≤ 10μM
|
Z80568-1-O |
UACC-257 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
790 |
0.26 |
Functional ≤ 10μM
|
Z80570-3-O |
UACC-62 (Melanoma Cells) (cluster #3 Of 3), Other |
Other |
28 |
0.32 |
Functional ≤ 10μM
|
Z80575-1-O |
UO-31 (Renal Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
191 |
0.29 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
9 |
0.34 |
Functional ≤ 10μM
|
Z80640-1-O |
786-0 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
33 |
0.32 |
Functional ≤ 10μM
|
Z80657-1-O |
A253 Cell Line (cluster #1 Of 1), Other |
Other |
3000 |
0.23 |
Functional ≤ 10μM
|
Z80682-11-O |
A549 (Lung Carcinoma Cells) (cluster #11 Of 11), Other |
Other |
5 |
0.35 |
Functional ≤ 10μM |
Z80682-11-O |
A549 (Lung Carcinoma Cells) (cluster #11 Of 11), Other |
Other |
37 |
0.32 |
Functional ≤ 10μM |
Z80711-1-O |
NCI/ADR-RES (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
78 |
0.30 |
Functional ≤ 10μM
|
Z80752-1-O |
Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
15 |
0.33 |
Functional ≤ 10μM
|
Z80789-1-O |
Colon 38 (cluster #1 Of 1), Other |
Other |
66 |
0.30 |
Functional ≤ 10μM
|
Z80815-1-O |
D54 Cell Line (cluster #1 Of 1), Other |
Other |
16 |
0.33 |
Functional ≤ 10μM
|
Z80830-1-O |
Ehrlich (Ehrlich Ascites Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
13 |
0.33 |
Functional ≤ 10μM
|
Z80847-1-O |
FaDu (Pharyngeal Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
31 |
0.32 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
9740 |
0.21 |
Functional ≤ 10μM
|
Z80890-1-O |
H350.3 (MTX-resistant Reuber Hepatoma Cells) (cluster #1 Of 1), Other |
Other |
906 |
0.26 |
Functional ≤ 10μM
|
Z80893-1-O |
H35 (Reuber Hepatoma Cells) (cluster #1 Of 1), Other |
Other |
10 |
0.34 |
Functional ≤ 10μM
|
Z80920-1-O |
HCC 2998 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
110 |
0.30 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
30 |
0.32 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
25 |
0.32 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
10 |
0.34 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
52 |
0.31 |
Functional ≤ 10μM
|
Z81065-1-O |
IGROV-1 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
65 |
0.30 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
6 |
0.35 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
6 |
0.35 |
Functional ≤ 10μM |
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
26 |
0.32 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
100 |
0.30 |
Functional ≤ 10μM
|
Z81281-1-O |
NCI-H23 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 5), Other |
Other |
43 |
0.31 |
Functional ≤ 10μM
|
Z81283-1-O |
NCI-H522 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
450 |
0.27 |
Functional ≤ 10μM
|
Z81322-1-O |
SF-539 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
35 |
0.32 |
Functional ≤ 10μM
|
Z81325-1-O |
SR (Leukemia Cells) (cluster #1 Of 2), Other |
Other |
33 |
0.32 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
33 |
0.32 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
30 |
0.32 |
Functional ≤ 10μM
|
Z80253-1-O |
MEF (Embryonic Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
120 |
0.29 |
ADME/T ≤ 10μM
|
Z80409-1-O |
R2 (cluster #1 Of 1), Other |
Other |
216 |
0.28 |
ADME/T ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.97 |
6.06 |
-125.84 |
5 |
13 |
-2 |
216 |
452.431 |
9 |
↓
|
Lo
Low (pH 4.5-6)
|
-1.97 |
6.52 |
-124.82 |
6 |
13 |
-1 |
217 |
453.439 |
9 |
↓
|
|
|
Analogs
-
1529323
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 18 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
B0BL08-1-B |
Dihydrofolate Reductase (cluster #1 Of 1), Bacterial |
Bacteria |
9 |
0.34 |
Binding ≤ 10μM
|
DYR-1-B |
Dihydrofolate Reductase (cluster #1 Of 4), Bacterial |
Bacteria |
9 |
0.34 |
Binding ≤ 10μM
|
DYR1-1-B |
Dihydrofolate Reductase Type 1 (cluster #1 Of 1), Bacterial |
Bacteria |
9 |
0.34 |
Binding ≤ 10μM
|
Q81R22-1-B |
Dihydrofolate Reductase (cluster #1 Of 1), Bacterial |
Bacteria |
15 |
0.33 |
Binding ≤ 10μM
|
TYSY-1-B |
Thymidylate Synthase (cluster #1 Of 1), Bacterial |
Bacteria |
1800 |
0.24 |
Binding ≤ 10μM
|
DYR-1-B |
Dihydrofolate Reductase (cluster #1 Of 1), Bacterial |
Bacteria |
26 |
0.32 |
Functional ≤ 10μM
|
DRTS-1-E |
Bifunctional Dihydrofolate Reductase-thymidylate Synthase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
33 |
0.32 |
Binding ≤ 10μM
|
DYR-1-E |
Dihydrofolate Reductase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
5 |
0.35 |
Binding ≤ 10μM
|
FOLC-1-E |
Folylpoly-gamma-glutamate Synthetase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3200 |
0.23 |
Binding ≤ 10μM
|
PTR1-1-E |
Pteridine Reductase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
39 |
0.31 |
Binding ≤ 10μM
|
S19A1-1-E |
Folate Transporter 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3500 |
0.23 |
Binding ≤ 10μM
|
TYSY-1-E |
Thymidylate Synthase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
3600 |
0.23 |
Binding ≤ 10μM
|
DYR-1-F |
Dihydrofolate Reductase (cluster #1 Of 1), Fungal |
Fungi |
880 |
0.26 |
Binding ≤ 10μM
|
Z103204-2-O |
A427 (cluster #2 Of 4), Other |
Other |
5520 |
0.22 |
Functional ≤ 10μM
|
Z50266-1-O |
Enterococcus Faecium (cluster #1 Of 1), Other |
Other |
90 |
0.30 |
Functional ≤ 10μM
|
Z50362-1-O |
Lactobacillus Casei (cluster #1 Of 1), Other |
Other |
6 |
0.35 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
85 |
0.30 |
Functional ≤ 10μM
|
Z50587-1-O |
Homo Sapiens (cluster #1 Of 9), Other |
Other |
6600 |
0.22 |
Functional ≤ 10μM
|
Z50594-1-O |
Mus Musculus (cluster #1 Of 9), Other |
Other |
4200 |
0.23 |
Functional ≤ 10μM
|
Z80001-1-O |
143B (cluster #1 Of 2), Other |
Other |
9 |
0.34 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
16 |
0.33 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.31 |
Functional ≤ 10μM
|
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
1100 |
0.25 |
Functional ≤ 10μM
|
Z80063-1-O |
CCRF S-180 (cluster #1 Of 1), Other |
Other |
10 |
0.34 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
8 |
0.34 |
Functional ≤ 10μM
|
Z80099-1-O |
COLO 205 (Colon Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
870 |
0.26 |
Functional ≤ 10μM
|
Z80112-1-O |
DAN-G (cluster #1 Of 2), Other |
Other |
77 |
0.30 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
45 |
0.31 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
8 |
0.34 |
Functional ≤ 10μM
|
Z80166-12-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #12 Of 12), Other |
Other |
4400 |
0.23 |
Functional ≤ 10μM |
Z80171-1-O |
HuTu80 (cluster #1 Of 1), Other |
Other |
9 |
0.34 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
26 |
0.32 |
Functional ≤ 10μM
|
Z80192-1-O |
KM12 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
42 |
0.31 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
10 |
0.34 |
Functional ≤ 10μM
|
Z80214-1-O |
M14 (Melanoma Cells) (cluster #1 Of 3), Other |
Other |
32 |
0.32 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
900 |
0.26 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
78 |
0.30 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
28 |
0.32 |
Functional ≤ 10μM
|
Z80354-1-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
400 |
0.27 |
Functional ≤ 10μM
|
Z80356-1-O |
OVCAR-5 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
980 |
0.25 |
Functional ≤ 10μM
|
Z80357-1-O |
OVCAR-8 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
31 |
0.32 |
Functional ≤ 10μM
|
Z80362-8-O |
P388 (Lymphoma Cells) (cluster #8 Of 8), Other |
Other |
66 |
0.30 |
Functional ≤ 10μM |
Z80390-3-O |
PC-3 (Prostate Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
27 |
0.32 |
Functional ≤ 10μM
|
Z80407-1-O |
R1 (cluster #1 Of 1), Other |
Other |
720 |
0.26 |
Functional ≤ 10μM
|
Z80408-1-O |
R1-CCRF-CEM (Lymphoblastic Leukemia) (cluster #1 Of 1), Other |
Other |
985 |
0.25 |
Functional ≤ 10μM
|
Z80409-1-O |
R2 (cluster #1 Of 1), Other |
Other |
2600 |
0.24 |
Functional ≤ 10μM
|
Z80410-1-O |
R2-CCRF-CEM (Lymphoblastic Leukemia) (cluster #1 Of 1), Other |
Other |
2630 |
0.24 |
Functional ≤ 10μM
|
Z80411-1-O |
R30dm-CCRF-CEM (Lymphoblastic Leukemia) (cluster #1 Of 1), Other |
Other |
18 |
0.33 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
33 |
0.32 |
Functional ≤ 10μM
|
Z80443-1-O |
S180 (Sarcoma Cells) (cluster #1 Of 1), Other |
Other |
5 |
0.35 |
Functional ≤ 10μM
|
Z80455-1-O |
SCC-15 (cluster #1 Of 1), Other |
Other |
580 |
0.26 |
Functional ≤ 10μM
|
Z80457-1-O |
SCC-25 (cluster #1 Of 1), Other |
Other |
8 |
0.34 |
Functional ≤ 10μM
|
Z80459-1-O |
SCC-7 (cluster #1 Of 1), Other |
Other |
6 |
0.35 |
Functional ≤ 10μM
|
Z80468-1-O |
SF-295 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
36 |
0.32 |
Functional ≤ 10μM
|
Z80488-2-O |
SK-MEL-5 (Melanoma Cells) (cluster #2 Of 3), Other |
Other |
87 |
0.30 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
15 |
0.33 |
Functional ≤ 10μM
|
Z80560-1-O |
U-251 (Glioma Cells) (cluster #1 Of 3), Other |
Other |
63 |
0.31 |
Functional ≤ 10μM
|
Z80563-1-O |
U-373 MG ( Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
12 |
0.34 |
Functional ≤ 10μM
|
Z80565-1-O |
U-87 MG (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
22 |
0.32 |
Functional ≤ 10μM
|
Z80568-1-O |
UACC-257 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
790 |
0.26 |
Functional ≤ 10μM
|
Z80570-3-O |
UACC-62 (Melanoma Cells) (cluster #3 Of 3), Other |
Other |
28 |
0.32 |
Functional ≤ 10μM
|
Z80575-1-O |
UO-31 (Renal Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
191 |
0.29 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
9 |
0.34 |
Functional ≤ 10μM
|
Z80640-1-O |
786-0 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
33 |
0.32 |
Functional ≤ 10μM
|
Z80657-1-O |
A253 Cell Line (cluster #1 Of 1), Other |
Other |
3000 |
0.23 |
Functional ≤ 10μM
|
Z80682-11-O |
A549 (Lung Carcinoma Cells) (cluster #11 Of 11), Other |
Other |
5 |
0.35 |
Functional ≤ 10μM |
Z80711-1-O |
NCI/ADR-RES (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
78 |
0.30 |
Functional ≤ 10μM
|
Z80752-1-O |
Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
15 |
0.33 |
Functional ≤ 10μM
|
Z80789-1-O |
Colon 38 (cluster #1 Of 1), Other |
Other |
66 |
0.30 |
Functional ≤ 10μM
|
Z80815-1-O |
D54 Cell Line (cluster #1 Of 1), Other |
Other |
16 |
0.33 |
Functional ≤ 10μM
|
Z80830-1-O |
Ehrlich (Ehrlich Ascites Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
13 |
0.33 |
Functional ≤ 10μM
|
Z80847-1-O |
FaDu (Pharyngeal Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
31 |
0.32 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
9740 |
0.21 |
Functional ≤ 10μM
|
Z80890-1-O |
H350.3 (MTX-resistant Reuber Hepatoma Cells) (cluster #1 Of 1), Other |
Other |
906 |
0.26 |
Functional ≤ 10μM
|
Z80893-1-O |
H35 (Reuber Hepatoma Cells) (cluster #1 Of 1), Other |
Other |
10 |
0.34 |
Functional ≤ 10μM
|
Z80920-1-O |
HCC 2998 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
110 |
0.30 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
30 |
0.32 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
25 |
0.32 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
10 |
0.34 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
52 |
0.31 |
Functional ≤ 10μM
|
Z81065-1-O |
IGROV-1 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
65 |
0.30 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
6 |
0.35 |
Functional ≤ 10μM |
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
26 |
0.32 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
100 |
0.30 |
Functional ≤ 10μM
|
Z81281-1-O |
NCI-H23 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 5), Other |
Other |
43 |
0.31 |
Functional ≤ 10μM
|
Z81283-1-O |
NCI-H522 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
450 |
0.27 |
Functional ≤ 10μM
|
Z81322-1-O |
SF-539 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
35 |
0.32 |
Functional ≤ 10μM
|
Z81325-1-O |
SR (Leukemia Cells) (cluster #1 Of 2), Other |
Other |
33 |
0.32 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
33 |
0.32 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
30 |
0.32 |
Functional ≤ 10μM
|
Z80409-1-O |
R2 (cluster #1 Of 1), Other |
Other |
216 |
0.28 |
ADME/T ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.97 |
6.03 |
-126.53 |
5 |
13 |
-2 |
216 |
452.431 |
9 |
↓
|
Lo
Low (pH 4.5-6)
|
-1.97 |
6.57 |
-124.3 |
6 |
13 |
-1 |
217 |
453.439 |
9 |
↓
|
|
|
Analogs
-
44136166
-
-
3954552
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 7 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
7510 |
0.34 |
Functional ≤ 10μM
|
Z80156-10-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #10 Of 12), Other |
Other |
1630 |
0.39 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
4670 |
0.36 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
625 |
0.41 |
Functional ≤ 10μM
|
Z80211-2-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
3500 |
0.36 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
9000 |
0.34 |
Functional ≤ 10μM
|
Z80354-1-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
2180 |
0.38 |
Functional ≤ 10μM
|
Z80362-3-O |
P388 (Lymphoma Cells) (cluster #3 Of 8), Other |
Other |
4560 |
0.36 |
Functional ≤ 10μM
|
Z80390-3-O |
PC-3 (Prostate Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
6380 |
0.35 |
Functional ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 11), Other |
Other |
4800 |
0.35 |
Functional ≤ 10μM
|
Z81017-2-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
2200 |
0.38 |
Functional ≤ 10μM
|
Z81020-4-O |
HepG2 (Hepatoblastoma Cells) (cluster #4 Of 8), Other |
Other |
6450 |
0.35 |
Functional ≤ 10μM
|
Z81024-2-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #2 Of 8), Other |
Other |
7800 |
0.34 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
680 |
0.41 |
Functional ≤ 10μM
|
Z81261-1-O |
UACC-375 (cluster #1 Of 1), Other |
Other |
2031 |
0.38 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
8800 |
0.34 |
Functional ≤ 10μM
|
Z81341-1-O |
Tumor Cell Lines (cluster #1 Of 1), Other |
Other |
2106 |
0.38 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.11 |
-0.46 |
-34.53 |
3 |
5 |
1 |
69 |
284.339 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.99 |
7.91 |
-20.82 |
0 |
14 |
0 |
175 |
384.305 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 36 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
5300 |
0.23 |
Binding ≤ 10μM
|
Z100250-1-O |
Calf Thymus DNA (cluster #1 Of 2), Other |
Other |
400 |
0.28 |
Binding ≤ 10μM
|
Z50380-1-O |
Mycobacterium Smegmatis (cluster #1 Of 4), Other |
Other |
9700 |
0.22 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
1259 |
0.26 |
Functional ≤ 10μM
|
Z50587-1-O |
Homo Sapiens (cluster #1 Of 9), Other |
Other |
10 |
0.35 |
Functional ≤ 10μM
|
Z80018-2-O |
A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other |
Other |
26 |
0.33 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
3600 |
0.24 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
6 |
0.36 |
Functional ≤ 10μM
|
Z80138-1-O |
G-361 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
1 |
0.39 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
8200 |
0.22 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
66 |
0.31 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
8700 |
0.22 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
7 |
0.36 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
10 |
0.35 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
10 |
0.35 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
9 |
0.35 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
30 |
0.33 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
28 |
0.33 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
12 |
0.35 |
Functional ≤ 10μM
|
Z80354-1-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
6 |
0.36 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
4 |
0.37 |
Functional ≤ 10μM
|
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
395 |
0.28 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
7 |
0.36 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.33 |
Functional ≤ 10μM
|
Z80463-1-O |
SCOV-3 (cluster #1 Of 1), Other |
Other |
5 |
0.36 |
Functional ≤ 10μM |
Z80475-2-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #2 Of 3), Other |
Other |
16 |
0.34 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
9800 |
0.22 |
Functional ≤ 10μM
|
Z80601-1-O |
XRS6 (cluster #1 Of 1), Other |
Other |
10 |
0.35 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
8000 |
0.22 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
3 |
0.37 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
7200 |
0.22 |
Functional ≤ 10μM
|
Z81017-2-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
8 |
0.35 |
Functional ≤ 10μM
|
Z81034-6-O |
A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
6 |
0.36 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
20 |
0.34 |
Functional ≤ 10μM
|
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
646 |
0.27 |
Functional ≤ 10μM
|
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
100 |
0.31 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
960 |
0.26 |
Functional ≤ 10μM
|
Z81261-1-O |
UACC-375 (cluster #1 Of 1), Other |
Other |
48 |
0.32 |
Functional ≤ 10μM
|
Z81341-1-O |
Tumor Cell Lines (cluster #1 Of 1), Other |
Other |
27 |
0.33 |
Functional ≤ 10μM
|
Q7ZJM1-1-V |
Human Immunodeficiency Virus Type 1 Integrase (cluster #1 Of 6), Viral |
Viruses |
8000 |
0.22 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.36 |
-2.16 |
-97.76 |
10 |
10 |
2 |
172 |
446.504 |
12 |
↓
|
Hi
High (pH 8-9.5)
|
0.36 |
-3.57 |
-51.37 |
9 |
10 |
1 |
168 |
445.496 |
12 |
↓
|
|